Orexo AB
F:C5G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
F:C5G
|
SE |
Intrinsic Value
The intrinsic value of 
Orexo AB (C5G) under the Base Case is 0.588 EUR per share.
Compared with the current market price of 0.228 EUR, the stock appears
Undervalued by 61% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Orexo AB Does
Orexo AB is a Swedish specialty pharmaceutical company that makes and sells medicines, mainly for opioid use disorder and other conditions where drug delivery matters. Its best-known product is Zubsolv, a prescription tablet that doctors use to help patients manage opioid dependence. The company also develops new formulations and delivery technologies that can make medicines easier to take or more reliable to use.
- Headquarters
- Sweden SE
- Employees
- 65
- IPO date
- Nov 9, 2005
Revenue & Expenses Breakdown
Orexo AB
Earnings Waterfall
Orexo AB
The intrinsic value for Orexo AB (C5G) under the Base Case is 0.588 EUR.
Compared with the current market price of 0.228 EUR, the stock appears Undervalued by 61% .
